Another study of 30 LN patients showed increased deposition of C9 in glomerular biopsy tissue in patients with worse disease compared to those with a more mild phenotype suggesting that the terminal complement complex (C5b-9) may be a suitable biomarker for LN disease activity [41]. Here, C9 is linked to lobular neoplasia.